Navigation Links
ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
Date:11/9/2009

Authors: G. L. Torkildsen, J. I. Williams, J. A. Gow, P. J. Gomes, T. R. McNamara

The Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis - Does Assumption of a Normal Data Distribution Influence the Means for Evaluating Clinical and Statistical Significance?

Authors: K. S. Kennedy, J. I. Williams, J. A. Gow, M. B. Abelson, T. R. McNamara

Abstracts are published in the November issue of Annals of Allergy, Asthma & Immunology and are available online at www.annallergy.org.

About Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5%

Bepreve is a non-sedating, highly selective antagonist of the histamine (H1) receptor. It has a stabilizing effect on mast cells, and it suppresses the migration of eosinophils into inflamed tissues. The compound's primary mechanisms of action are believed to make it an effective treatment against ocular itching associated with allergic conjunctivitis.

Bepreve was approved by the U.S. Food and Drug Administration in September 2009 for the treatment of ocular itching associated with allergic conjunctivitis. Bepotastine has been approved in Japan for systemic use in the treatment of allergic rhinitis since 2000 and urticaria/pruritus since 2002. It is marketed in Japan by Mitsubishi Tanabe Pharma Corporation (formerly Tanabe Seiyaku Co., Ltd.) under the brand name TALION®. TALION was co-developed by Tanabe Seiyaku and Ube Industries, Ltd., who discovered bepotastine. In 2001, Tanabe Seiyaku granted Senju Pharmaceutical Co., Ltd., exclusive worldwide rights, with the exception of certain Asian countries, to develop, manufacture and market bepotastine for ophthalmic use. In 2006, ISTA licensed the exclusive North American rights from Senju to an eye drop formulation of bepotastine for the treatment of allergic conjunctivitis. In 2007, ISTA licensed exclusive North
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration
2. DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
3. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
4. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
5. Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
6. Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
9. Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
10. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
11. VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...DIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(...opingproductsforminimallydisruptivesurgicaltreatme...encecallonMonday,November30,2009,at5:30p.m.ET/2:30...lativetoreimbursementfortheCompany,sproductsandwil...tionandanswersession.Thedial-innumbersare1-877-407...
(Date:11/25/2009)...MINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall...IN),aleadinginnovatorandprovideroflessinvasive,min...zingthetreatmentofadvancedheartfailure,todayannoun...the21stAnnualPiperJaffrayHealthCareConferenceat8:0...ingheldattheNewYorkPalaceHotel,December1-2. ,, ...
(Date:11/24/2009)...ISON,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiagn...oviderofdiagnostictesting,informationandservices,a...erJaffrayHealthcareConferenceinNewYorkCity.Thepres...30a.m.EasternTime. ,, Duringtheconference,theco...approximate3%,operatingincometoexceed18%ofrevenues...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting fo 4532 1Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting fo 4532 2Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting fo 4532 3Definitive Outcomes of Radiofrequency Ablation for Barretts Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting fo 4532 4Changing climate likely to make super weed even more powerful 8710 1Changing climate likely to make super weed even more powerful 8710 2Biopolymers Symposium 2009 Announces Final Program and Interactive Green Brochure 47814 1Biopolymers Symposium 2009 Announces Final Program and Interactive Green Brochure 47814 2
...LOS ANGELES--(BUSINESS WIRE)--Jun 25, 2007 - CytRx...mpany engaged in the,development and commercializa...and tolerability results from its previously,annou...iple dose,clinical trial in healthy volunteers wit...hat the results of this trial support,the use of a...
...Minimal Weight Change Reported Unlike What Is Comm...07 /PRNewswire-FirstCall/ -- Novo Nordisk,today an...trated,the safety and efficacy of insulin Levemir(...ents with type 2 diabetes were able,to adjust thei...s,in blood sugar, comparable to dosing adjusted by...
Other Medicine Technology:CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 2CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 3CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 4CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS 5New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5
(Date:11/25/2009)...e/--TheBlackAIDSInstituterecentlyheldBoardofDirect...,, ThenewBoardMembersareahighlydiversegroupofle...ernmenthealthprograms,editorial,andbusinessentrepr...lbackgroundsincludingbothheterosexualandgayBlackme...ingmultipleagegroups. ,, (Photo: http://www.new...
(Date:11/25/2009)... were treated with cisplatin-based chemotherapy ha... side effects and Raynaud-like phenomena, than men... to a new study published online November 25 in th...Marianne Brydy, M.D., of the Department of Oncolog...y, and colleagues conducted a cross-sectional stud...
(Date:11/25/2009)...imple question has been the focus of intense resea...ates High Blood Pressure in Mice & Men, Does stre...has been the focus of intense research for many ye...blished a link between a novel gene, phosducin, an... well as humans. The studies were directed by scie...
(Date:11/25/2009)...ment clinics to resume Monday, Nov. 30 , ...9 -- Centegra Health System is continuing to offer...r Centegra Primary Care (CPC) vaccination clinics ... clinics are at CPC sites in Huntley, Woodstock, C...s: ,   From 4:30 to 7:30 p.m. Tuesday,...
(Date:11/25/2009)...rouble with the H1N1 vaccine, , , WEDNE... swine flu pandemic may be driving a recent spike ...U.S. health official said Wednesday. , "We are ...ons around the country," Dr. Anne Schuchat, direct...piratory Diseases at the U.S. Centers for Disease ...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...t of quick, non-invasive identification of the dan...althDay News) -- Doctors may some day be able to a...ng cancer with nothing more than a quick swab of t...sue damage following long-term exposure to tobacco...
... April 16 Xceed Molecular, a pioneer,in the devel...ion analysis,systems, announced that the Universit...ator program. Xceed will work with primary researc...,an expression signature that has shown promise as...
... Required to Provide Calorie Information, ALEXAND...ion (ADA) applauds today,s federal court ruling up...hain restaurants to provide the,calorie content of...n. The ADA appeared as an amicus curiae along with...
...Calif., April 16 Consumer,Watchdog today joined L...he,city,s lawsuit alleging that health insurer Blu...legally cancelling the health insurance of patient..., and facing up to,hundreds of thousands of dollar...
...April 16 MedCath Corporation,(Nasdaq: MDTH ) ann...n,appointed to its Board of Directors., Mr. Gross...xperience to,the MedCath Board of Directors. He se...ewaterhouse Coopers, he also,served as the audit p...
...ril 16 Law Offices of Howard G. Smith,announces t...nverness,Medical Innovations, Inc. ("Inverness Med...sible securities law violations by Inverness Medic...rns alleged misrepresentations or omissions in,con...
Other Medicine News:Health News:Mouth Swab May One Day Diagnose Lung Cancer 2Health News:Mouth Swab May One Day Diagnose Lung Cancer 3Health News:Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer 2Health News:Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer 3Health News:Statement of the American Diabetes Association Supporting Federal Court's Ruling on New York City Proposal 2Health News:Consumer Watchdog Applauds L.A. City Attorney's Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Do Same 2Health News:Woodrin 'Woody' Grossman Appointed to MedCath's Board of Directors 2
Slick Set® Uncuffed
Cuffed Nasoral Magill
...ft white rubber tube with Murphy eye. Laser resist...h volume cuffs (One inside other) 40cm (16") long,...w maximum access and optimum visibility within the...ilation. The tube shaft has a special laser-guard ...
Left Carlens Carina Hook
Medicine Products: